English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51405700    Online Users :  992
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"wu s g"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 16-25 of 224  (23 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-06-27T07:01:45Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; CHONG-JEN YU; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:01:41Z Treatment outcome of patients with isoniazid mono-resistant tuberculosis Chien J.-Y.; Chen Y.-T.; Wu S.-G.; Lee J.-J.; Wang J.-Y.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:01:38Z Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion Tsai T.-H.; Wu S.-G.; Hsieh M.-S.; CHONG-JEN YU; Yang J.C.H.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:00:26Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:00:23Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:00:19Z Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:00:16Z The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:00:08Z Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T06:59:59Z Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2022-06-27T06:59:56Z IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; CHONG-JEN YU; Shih J.-Y.

Showing items 16-25 of 224  (23 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page